S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Why do tech stocks go down when interest rates rise?
Pure Storage stock fumbles for a rare buying opportunity
All the trading advice you’ve ever received boils down to this (Ad)
Snowflake’s bullish tailwind is turning into a gale-force wind
2 energy drink makers to wake up your portfolio
All the trading advice you’ve ever received boils down to this (Ad)
Bitcoin has surpassed $41,000 for the first time since April 2022. What's behind the price surge?
Doing Your Holiday Shopping? These Stocks Might Make Great Gifts
S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Why do tech stocks go down when interest rates rise?
Pure Storage stock fumbles for a rare buying opportunity
All the trading advice you’ve ever received boils down to this (Ad)
Snowflake’s bullish tailwind is turning into a gale-force wind
2 energy drink makers to wake up your portfolio
All the trading advice you’ve ever received boils down to this (Ad)
Bitcoin has surpassed $41,000 for the first time since April 2022. What's behind the price surge?
Doing Your Holiday Shopping? These Stocks Might Make Great Gifts
S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Why do tech stocks go down when interest rates rise?
Pure Storage stock fumbles for a rare buying opportunity
All the trading advice you’ve ever received boils down to this (Ad)
Snowflake’s bullish tailwind is turning into a gale-force wind
2 energy drink makers to wake up your portfolio
All the trading advice you’ve ever received boils down to this (Ad)
Bitcoin has surpassed $41,000 for the first time since April 2022. What's behind the price surge?
Doing Your Holiday Shopping? These Stocks Might Make Great Gifts
S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Why do tech stocks go down when interest rates rise?
Pure Storage stock fumbles for a rare buying opportunity
All the trading advice you’ve ever received boils down to this (Ad)
Snowflake’s bullish tailwind is turning into a gale-force wind
2 energy drink makers to wake up your portfolio
All the trading advice you’ve ever received boils down to this (Ad)
Bitcoin has surpassed $41,000 for the first time since April 2022. What's behind the price surge?
Doing Your Holiday Shopping? These Stocks Might Make Great Gifts

Carl Zeiss Meditec (AFX) Stock Forecast & Price Target

€82.46
-1.68 (-2.00%)
(As of 12/4/2023 ET)
Compare
Today's Range
€81.40
€84.62
50-Day Range
€74.02
€87.08
52-Week Range
€72.60
€142.75
Volume
149,568 shs
Average Volume
94,405 shs
Market Capitalization
$7.38 billion
P/E Ratio
23.97
Dividend Yield
1.33%
Price Target
€167.50

Carl Zeiss Meditec Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

N/A
Based on 0 Analyst Ratings

Analysts' Consensus Price Target

€167.50
High Forecast€195.00
Average Forecast€167.50
Low Forecast€138.00
TypeCurrent Forecast
12/5/22 to 12/5/23
1 Month Ago
11/5/22 to 11/5/23
3 Months Ago
9/6/22 to 9/6/23
1 Year Ago
12/5/21 to 12/5/22
Consensus RatingN/AN/AN/AN/A
Strong Buy N/A N/A N/A N/A
Buy N/A N/A N/A N/A
Hold N/A N/A N/A N/A
Sell N/A N/A N/A N/A
Consensus Price Target€167.50€167.50€167.50€170.29
Get Carl Zeiss Meditec Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for AFX and its competitors with MarketBeat's FREE daily newsletter.


AFX Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

AFX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Carl Zeiss Meditec Stock vs. The Competition

TypeCarl Zeiss MeditecMedical Companies
Consensus Rating Score
0.00
2.67
Consensus RatingN/AModerate Buy
News Sentiment RatingNeutral News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/31/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Falko Friedrichs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€175.00+40.06%
3/22/2023Hauck Aufhäuser Investment Banking
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Alexander Galitsa
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€195.00+48.57%
3/22/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Graham Doyle
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€162.00+23.43%
2/13/2023Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Beatrice Allen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€138.00+4.82%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 06:47 AM ET.












AFX Price Target - Frequently Asked Questions

Does Carl Zeiss Meditec's stock price have much upside?

According to analysts, Carl Zeiss Meditec's stock has a predicted upside of 29.07% based on their 12-month stock forecasts.


Stock Ratings Reports and Tools

This page (ETR:AFX) was last updated on 12/5/2023 by MarketBeat.com Staff

My Account -